Literature DB >> 7795451

GR106642X: a new, non-ozone depleting propellant for inhalers.

S C Taggart1, A Custovic, D H Richards, A Woodcock.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7795451      PMCID: PMC2550012          DOI: 10.1136/bmj.310.6995.1639a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects.

Authors:  P J Barnes; N B Pride
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

2.  Rapid method for measurement of bronchial responsiveness.

Authors:  K Yan; C Salome; A J Woolcock
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

3.  A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects.

Authors:  A J Knox; A Wisniewski; S Cooper; A E Tattersfield
Journal:  Eur Respir J       Date:  1991-04       Impact factor: 16.671

  3 in total
  4 in total

1.  Generic inhaled salbutamol versus branded salbutamol. A randomised double-blind study.

Authors:  I J Williamson; A Reid; R D Monie; A G Fennerty; E M Rimmer
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

2.  Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.

Authors:  F S Ram; J Wright; D Brocklebank; J E White
Journal:  BMJ       Date:  2001-10-20

Review 3.  Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.

Authors:  D A Hughes; A Woodcock; T Walley
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

4.  Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.